The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features.

MLA

Sheikholeslami, Sara, et al. “The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and Its Effects on Clinic-Pathological Features.” Iranian Journal of Public Health, vol. 51, no. 3, Mar. 2022, pp. 634–42. EBSCOhost, https://doi.org/10.18502/ijph.v51i3.8940.

APA

Sheikholeslami, S., Azizi, F., Ghasemi, A., Alibakhshi, A., Parsa, H., Shivaee, S., Zarif-Yeganeh, M., Hedayati, M., & Teimoori-Toolabi, L. (2022). The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features. Iranian Journal of Public Health, 51(3), 634–642. https://doi.org/10.18502/ijph.v51i3.8940

Chicago

Sheikholeslami, Sara, Fereidoun Azizi, Asghar Ghasemi, Abbas Alibakhshi, Hossein Parsa, Setareh Shivaee, Marjan Zarif-Yeganeh, Mehdi Hedayati, and Ladan Teimoori-Toolabi. 2022. “The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and Its Effects on Clinic-Pathological Features.” Iranian Journal of Public Health 51 (3): 634–42. doi:10.18502/ijph.v51i3.8940.